Topical Calcipotriol Plus Imiquimod Immunotherapy for Nonkeratinocyte Skin Cancers
Nonkeratinocyte cutaneous malignancies, including breast cancer cutaneous metastasis and melanoma in situ, are often poor surgical candidates. Imiquimod (IMQ), a toll-like receptor 7 agonist that activates innate immunity in the skin, is used to treat these cutaneous malignancies. However, IMQ'...
Saved in:
Main Authors: | Marjan Azin (Author), Kenneth H. Ngo (Author), Jennet Hojanazarova (Author), Shadmehr Demehri (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2023-11-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Topical Calcipotriol Plus 5-Fluorouracil Immunotherapy for Actinic Keratosis Treatment
by: Marjan Azin, et al.
Published: (2022) -
Calcipotriol Plus Betamethasone Dipropionate Aerosol Foam For Scalp Psoriasis
by: Anderko M, et al.
Published: (2019) -
Topical imiquimod and cryotherapy in combination with systemic immunotherapy in unresectable stage IIIC melanoma
by: Jennifer E. Yeh, MD, PhD, et al.
Published: (2022) -
Galenic concept of supersaturation may improve the cutaneous absorption of calcipotriol plus betamethasone dipropionate aerosol foam compared with other topical formulations
by: Rudolf E. Schopf
Published: (2024) -
Sorafenib-asssociated hand-foot syndrome treated with topical calcipotriol
by: Serkan Demirkan, MD, et al.
Published: (2017)